On Friday, Bristol-Myers Squibb Co (NYSE: BMY) opened higher 2.36% from the last session, before settling in for the closing price of $51.2. Price fluctuations for BMY have ranged from $42.52 to $63.33 over the past 52 weeks.
Company’s average yearly earnings per share was noted 466.74% at the time writing. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.04 billion.
Bristol-Myers Squibb Co (BMY) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Bristol-Myers Squibb Co is 0.18%, while institutional ownership is 81.02%. The most recent insider transaction that took place on Sep 02 ’25, was worth 2,650,480. In this transaction EVP, Chief Financial Officer of this company sold 56,000 shares at a rate of $47.33, taking the stock ownership to the 167,379 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Officer proposed sale 56,000 for $47.30, making the entire transaction worth $2,648,800.
Bristol-Myers Squibb Co (BMY) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 1.67 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 1.47) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 466.74% per share during the next fiscal year.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
Check out the current performance indicators for Bristol-Myers Squibb Co (BMY). In the past quarter, the stock posted a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22. Likewise, its price to free cash flow for the trailing twelve months is 6.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.96, a number that is poised to hit 1.62 in the next quarter and is forecasted to reach 6.00 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
Let’s dig in a bit further. During the last 5-days, its volume was 13.77 million. That was inferior than the volume of 13.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.67%.
During the past 100 days, Bristol-Myers Squibb Co’s (BMY) raw stochastic average was set at 94.46%, which indicates a significant increase from 89.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.12 in the past 14 days, which was higher than the 1.05 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.71, while its 200-day Moving Average is $48.93. However, in the short run, Bristol-Myers Squibb Co’s stock first resistance to watch stands at $52.93. Second resistance stands at $53.45. The third major resistance level sits at $53.91. If the price goes on to break the first support level at $51.95, it is likely to go to the next support level at $51.49. Assuming the price breaks the second support level, the third support level stands at $50.97.
Bristol-Myers Squibb Co (NYSE: BMY) Key Stats
There are currently 2,035,753K shares outstanding in the company with a market cap of 106.69 billion. Presently, the company’s annual sales total 48,300 M according to its annual income of -8,948 M. Last quarter, the company’s sales amounted to 12,222 M and its income totaled 2,201 M.
